^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    PIM1 mutation

    i
    Entrez ID:
    5292
    Related biomarkers:
    Expression
    Apply
    Identification Predictive Markers of Immunochemotherapy Response to the Primary Cutaneous Diffuse Large B Cell Lymphoma (PROTEOM) (NCT04183569)
    Phase N/A
    University Hospital, Bordeaux
    Unknown status
    Last update posted :
    04/29/2020
    Initiation :
    02/19/2019
    Primary completion :
    05/01/2020
    Completion :
    05/01/2020
    BCL2 • CDKN2A • MYD88 • CD79B • TNFAIP3 • PIM1 • PRDM1
    |
    CDKN2A deletion • MYD88 mutation • CD79B mutation • PIM1 mutation